Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial

Messoud Ashina; Peter J. Goadsby; Uwe Reuter; Stephen Silberstein; David W. Dodick; Fei Xue; Feng Zhang; Gabriel Paiva Da Silva Lima; Sunfa Cheng; Daniel D. Mikol

doi:10.1111/ene.14715

Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial

Messoud Ashina, Peter J. Goadsby, Uwe Reuter, Stephen Silberstein, David W. Dodick, Fei Xue, Feng Zhang, Gabriel Paiva Da Silva Lima, Sunfa Cheng, Daniel D. Mikol

Research output: Contribution to journal › Journal article › Research › peer-review

131 Citations (Scopus)

16 Downloads (Pure)

Original language	English
Journal	European Journal of Neurology
Volume	28
Issue number	5
Pages (from-to)	1716-1725
Number of pages	10
ISSN	1351-5101
DOIs	https://doi.org/10.1111/ene.14715
Publication status	Published - 1 May 2021

Access to Document

10.1111/ene.14715Licence: CC BY-NC

ene.14715Final published version, 886 KBLicence: CC BY-NC

Cite this

Ashina, M., Goadsby, P. J., Reuter, U., Silberstein, S., Dodick, D. W., Xue, F., Zhang, F., Paiva Da Silva Lima, G., Cheng, S., & Mikol, D. D. (2021). Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial. European Journal of Neurology, 28(5), 1716-1725. https://doi.org/10.1111/ene.14715

Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial. / Ashina, Messoud; Goadsby, Peter J.; Reuter, Uwe; Silberstein, Stephen; Dodick, David W.; Xue, Fei; Zhang, Feng; Paiva Da Silva Lima, Gabriel; Cheng, Sunfa; Mikol, Daniel D.

In: European Journal of Neurology, Vol. 28, No. 5, 01.05.2021, p. 1716-1725.

Research output: Contribution to journal › Journal article › Research › peer-review

Ashina, M, Goadsby, PJ, Reuter, U, Silberstein, S, Dodick, DW, Xue, F, Zhang, F, Paiva Da Silva Lima, G, Cheng, S & Mikol, DD 2021, 'Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial', European Journal of Neurology, vol. 28, no. 5, pp. 1716-1725. https://doi.org/10.1111/ene.14715

Ashina, Messoud ; Goadsby, Peter J. ; Reuter, Uwe ; Silberstein, Stephen ; Dodick, David W. ; Xue, Fei ; Zhang, Feng ; Paiva Da Silva Lima, Gabriel ; Cheng, Sunfa ; Mikol, Daniel D. / Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial. In: European Journal of Neurology. 2021 ; Vol. 28, No. 5. pp. 1716-1725.

@article{de206c7096084320bb102c59ff7123ff,

title = "Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial",

author = "Messoud Ashina and Goadsby, {Peter J.} and Uwe Reuter and Stephen Silberstein and Dodick, {David W.} and Fei Xue and Feng Zhang and {Paiva Da Silva Lima}, Gabriel and Sunfa Cheng and Mikol, {Daniel D.}",

year = "2021",

month = may,

day = "1",

doi = "10.1111/ene.14715",

language = "English",

volume = "28",

pages = "1716--1725",

journal = "European Journal of Neurology",

issn = "1351-5101",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Long‐term efficacy and safety of erenumab in migraine prevention: Results from a 5‐year, open‐label treatment phase of a randomized clinical trial

AU - Ashina, Messoud

AU - Goadsby, Peter J.

AU - Reuter, Uwe

AU - Silberstein, Stephen

AU - Dodick, David W.

AU - Xue, Fei

AU - Zhang, Feng

AU - Paiva Da Silva Lima, Gabriel

AU - Cheng, Sunfa

AU - Mikol, Daniel D.

PY - 2021/5/1

Y1 - 2021/5/1

U2 - 10.1111/ene.14715

DO - 10.1111/ene.14715

M3 - Journal article

C2 - 33400330

VL - 28

SP - 1716

EP - 1725

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 5

ER -